共 50 条
- [41] INTRINSIC BACTERICIDAL CAPACITY OF PHAGOCYTOSIS AGAINST STREPTOCOCCUS GROUP-B OF TYPE-IA AND TYPE-III IN THE HUMAN NEWBORN ARCHIVOS DE INVESTIGACION MEDICA, 1981, 12 (04): : S62 - S62
- [42] FIBRONECTIN AND AGE-LIMITED SUSCEPTIBILITY TO TYPE-III, GROUP-B STREPTOCOCCUS JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02): : 471 - 474
- [43] COMPARISON OF ASSAYS FOR ANTIBODY TO GROUP-B-STREPTOCOCCUS, TYPE-III JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (04): : 530 - 530
- [44] A SIALIC-ACID DEFICIENT MUTANT OF TYPE-III GROUP-B STREPTOCOCCUS CLINICAL RESEARCH, 1988, 36 (03): : A475 - A475
- [46] MECHANISM OF ALTERNATIVE COMPLEMENT PATHWAY INHIBITION BY TYPE-III GROUP-B STREPTOCOCCUS CLINICAL RESEARCH, 1981, 29 (02): : A532 - A532
- [47] TYPE-III GROUP-B STREPTOCOCCUS - FUNCTIONAL INTERACTION WITH IGG SUBCLASS ANTIBODIES JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (03): : 532 - 539
- [48] IMMUNOCHEMICAL CHARACTERIZATION OF NATIVE POLYSACCHARIDES FROM GROUP-B STREPTOCOCCUS - RELATIONSHIP OF TYPE-III AND GROUP-B DETERMINANTS JOURNAL OF IMMUNOLOGY, 1978, 121 (03): : 1096 - 1105
- [49] INTRAVENOUS IMMUNOGLOBULIN ENHANCES THE DEPOSITION OF IGG AND C3 ONTO TYPE-III GROUP-B STREPTOCOCCUS CLINICAL RESEARCH, 1990, 38 (04): : A976 - A976
- [50] RIFAMPIN TREATMENT OF INFANT RATS NASALLY COLONIZED WITH TYPE-III GROUP-B STREPTOCOCCI (GBS) CLINICAL RESEARCH, 1983, 31 (04): : A788 - A788